Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 1 / Phase 2	2026-04-09		NCT07319676

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National University Hospital, Singapore	120

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National University Hospital	Singapore	Singapore	8

Clinical trials